Scinai Immunotherapeutics Ltd. (SCNI) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for this public event.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04098-bef0-78c0-87df-639532bb8617 Created: 2026-08-27T00:22:29.082Z Duration: 1757.1787 Channels: 1 00:00:01.680 -- 00:00:04.000 All right. I think we're live now. So 00:00:04.000 -- 00:00:05.839 let's jump in. Thank you, everyone, for joining 00:00:05.839 -- 00:00:07.919 today. SINAi Immunotherapeutics 00:00:07.919 -- 00:00:09.200 corporate overview 00:00:09.599 -- 00:00:12.400 and 2026 mid year business update. My name 00:00:12.400 -- 00:00:14.559 is Andrew Erickson. I'm a managing director 00:00:14.875 -- 00:00:16.875 here at Allel Capital who works directly with 00:00:16.875 -- 00:00:19.035 the SINAI team and we're helping put on 00:00:19.035 -- 00:00:20.075 this event today. 00:00:20.795 -- 00:00:23.035 I'm going to run through a bit of 00:00:23.035 -- 00:00:23.675 the 00:00:23.994 -- 00:00:25.835 first half results that you might have noticed 00:00:25.835 -- 00:00:26.635 SINAI 00:00:26.635 -- 00:00:28.154 published just yesterday. 00:00:28.570 -- 00:00:30.250 I'll review some of those financials, some of 00:00:30.250 -- 00:00:31.930 those business updates, and then Amir is going 00:00:31.930 -- 00:00:33.050 to give us a bit of an outlook 00:00:33.050 -- 00:00:34.890 for the rest of 2026 00:00:34.890 -- 00:00:37.290 and why the team is ultimately really excited 00:00:37.290 -- 00:00:38.650 about what's to come. 00:00:39.370 -- 00:00:42.170 Without further ado, we'll get into it and 00:00:42.170 -- 00:00:43.930 then we'll save the questions at the end. 00:00:44.245 -- 00:00:46.485 If you're watching on LinkedIn or YouTube, there's 00:00:46.485 -- 00:00:48.965 chat boxes for both of those platforms. 00:00:49.285 -- 00:00:50.885 Submit your questions and we'll get to those 00:00:50.885 -- 00:00:52.485 at...